Cost-Effectiveness Analyses of Hepatitis A Vaccine
- 1 January 2008
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 26 (1), 17-32
- https://doi.org/10.2165/00019053-200826010-00003
Abstract
Cost-effectiveness/cost-utility studies of hepatitis A vaccine were identified via a series of literature searches (MEDLINE, EMBASE, HSTAR and SSCI). Citations and full-text articles were reviewed...Keywords
This publication has 65 references indexed in Scilit:
- Hepatitis A in the Era of VaccinationEpidemiologic Reviews, 2006
- Hepatitis A Virus Infections in Travelers, 1988-2004Clinical Infectious Diseases, 2006
- Good Practice Guidelines for Decision-Analytic Modelling in Health Technology AssessmentPharmacoEconomics, 2006
- Hepatitis A — The Price of ProgressNew England Journal of Medicine, 2005
- Regional variation in the cost effectiveness of childhood hepatitis A immunizationThe Pediatric Infectious Disease Journal, 2003
- Economic Evaluation of Vaccination ProgrammesPharmacoEconomics, 2002
- The cost of hepatitis A infections in American adolescents and adults in 1997Hepatology, 2000
- Interpretation of cost-effectiveness analysesJournal of General Internal Medicine, 1998
- Cost Effectiveness of Hepatitis A Prevention in FrancePharmacoEconomics, 1995
- Age-related changes in the rate of disease transmission: implications for the design of vaccination programmesEpidemiology and Infection, 1985